Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2001 Jul 7;323(7303):13-6.
doi: 10.1136/bmj.323.7303.13.

Are cannabinoids an effective and safe treatment option in the management of pain? A qualitative systematic review

F A Campbell  1 , M R Tramèr, D Carroll, D J Reynolds, R A Moore, H J McQuay
Affiliations

Are cannabinoids an effective and safe treatment option in the management of pain? A qualitative systematic review

F A Campbell et al. BMJ. .

Abstract

Objective: To establish whether cannabis is an effective and safe treatment option in the management of pain.

Design: Systematic review of randomised controlled trials.

Data sources: Electronic databases Medline, Embase, Oxford Pain Database, and Cochrane Library; references from identified papers; hand searches.

Study selection: Trials of cannabis given by any route of administration (experimental intervention) with any analgesic or placebo (control intervention) in patients with acute, chronic non-malignant, or cancer pain. Outcomes examined were pain intensity scores, pain relief scores, and adverse effects. Validity of trials was assessed independently with the Oxford score.

Data extraction: Independent data extraction; discrepancies resolved by consensus.

Data synthesis: 20 randomised controlled trials were identified, 11 of which were excluded. Of the 9 included trials (222 patients), 5 trials related to cancer pain, 2 to chronic non-malignant pain, and 2 to acute postoperative pain. No randomised controlled trials evaluated cannabis; all tested active substances were cannabinoids. Oral delta-9-tetrahydrocannabinol (THC) 5-20 mg, an oral synthetic nitrogen analogue of THC 1 mg, and intramuscular levonantradol 1.5-3 mg were about as effective as codeine 50-120 mg, and oral benzopyranoperidine 2-4 mg was less effective than codeine 60-120 mg and no better than placebo. Adverse effects, most often psychotropic, were common.

Conclusion: Cannabinoids are no more effective than codeine in controlling pain and have depressant effects on the central nervous system that limit their use. Their widespread introduction into clinical practice for pain management is therefore undesirable. In acute postoperative pain they should not be used. Before cannabinoids can be considered for treating spasticity and neuropathic pain, further valid randomised controlled studies are needed.

PubMed Disclaimer

Figures

Figure
Figure
Results of search of Medline, Embase, Oxford Pain Database, Cochrane Library, references on identified papers; and hand searches for work on cannabinoids and pain
See this image and copyright information in PMC

Comment in

References

    1. Martin WJ, Loo CM, Basbaum AI. Cannabinoids are anti-allodynic in rats with persistent inflammation. Pain. 1999;82(2):199–205. - PubMed
    1. Martin WJ. Basic mechanisms of cannabinoid-induced analgesia. IASP Newsletter 1999;summer:3-6.
    1. Ashton CH. Adverse effects of cannabis and cannabinoids. Br J Anaesth. 1999;83:637–649. - PubMed
    1. BM Association. Therapeutic uses of cannabis. Amsterdam: Harwood Academic; 1997.
    1. Meek C. Doctors want cannabis prescriptions allowed. BMA News Review 1994;February:1-19.

Publication types

MeSH terms